Research Paper Volume 13, Issue 23 pp 25304—25324
GDI2 is a novel diagnostic and prognostic biomarker in hepatocellular carcinoma
Figure 4. Association between GDI2 expression and clinical characteristics. (A–I) Violin images for clinicopathologic characteristics as (A) T stage; (B) Pathologic stage; (C) Histologic grade, (D) AFP(ng/ml); (E) TP53 status; and (F) tumor status, as well as Physical index as (G) Age; (H) Weight; (I) BMI, demonstrated significant association with GDI2 expression by Wilcoxon rank sum test. *P < 0.05,**P < 0.01.